These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2884288)

  • 1. A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil.
    Watkins WM; Chulay JD; Sixsmith DG; Spencer HC; Howells RE
    J Pharm Pharmacol; 1987 Apr; 39(4):261-5. PubMed ID: 2884288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorproguanil and chlorcycloguanil concentrations in human plasma and urine after Lapudrine administration.
    Edstein MD; Veenendaal JR
    Trans R Soc Trop Med Hyg; 1987; 81(1):136-9. PubMed ID: 3445299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo susceptibility of Plasmodium falciparum isolates from Liberia to pyrimethamine, cycloguanil and chlorcycloguanil.
    Petersen E; Hogh B; Hanson AP; Bjorkman A; Flacks H
    Ann Trop Med Parasitol; 1990 Dec; 84(6):563-71. PubMed ID: 2076034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
    Wright JD; Helsby NA; Ward SA
    Br J Clin Pharmacol; 1995 Apr; 39(4):441-4. PubMed ID: 7640152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
    Simpson JA; Hughes D; Manyando C; Bojang K; Aarons L; Winstanley P; Edwards G; Watkins WA; Ward S
    Br J Clin Pharmacol; 2006 Mar; 61(3):289-300. PubMed ID: 16487222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
    Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
    Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range.
    Winstanley P; Watkins W; Muhia D; Szwandt S; Amukoye E; Marsh K
    Trans R Soc Trop Med Hyg; 1997; 91(3):322-7. PubMed ID: 9231209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
    Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
    Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
    Stewart LB; Peters W; Robinson BL
    Ann Trop Med Parasitol; 2004 Dec; 98(8):763-83. PubMed ID: 15667710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily chlorproguanil is an effective alternative to daily proguanil in the prevention of Plasmodium falciparum malaria in Kenya.
    Nevill CG; Lury JD; Mosobo MK; Watkins HM; Watkins WM
    Trans R Soc Trop Med Hyg; 1994; 88(3):319-20. PubMed ID: 7974677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of chlorproguanil in man after a single oral dose of Lapudrine.
    Veenendaal JR; Edstein MD; Rieckmann KH
    Chemotherapy; 1988; 34(4):275-83. PubMed ID: 3208546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
    Peters W; Stewart LB; Robinson BL
    Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro sensitivity of Plasmodium falciparum to chlorcycloguanil in The Gambia.
    Panton LJ; Greenwood BM
    Trans R Soc Trop Med Hyg; 1985; 79(4):491-2. PubMed ID: 3909555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
    Watkins WM; Sixsmith DG; Chulay JD
    Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pharmacokinetics of proguanil and its metabolites.
    Bygbjerg I; Ravn P; Rønn A; Flachs H; Hvidberg EF
    Trop Med Parasitol; 1987 Jun; 38(2):77-80. PubMed ID: 3629140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil.
    Matthaei J; Seitz T; Jensen O; Tann A; Prukop T; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
    Clin Pharmacol Ther; 2019 Jan; 105(1):190-200. PubMed ID: 29882324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro.
    Eriksson B; Courtier B; Bjŏrkman A; Miltgen F; Mazier D
    Trans R Soc Trop Med Hyg; 1991; 85(6):725-6. PubMed ID: 1801335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of the efficacy of the chemoprevention of malaria using chlorproguanil alone or in combination with chloroquine in French expatriates in Dar-es-Salaam, Tanzania].
    Ringwald P; Le Bras J; Havermann K; Flachs H
    Bull Soc Pathol Exot Filiales; 1989 Jan; 82(1):124-9. PubMed ID: 2743514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
    Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
    J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
    Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
    Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.